​Using the specially developed Sanakin Technology, an Autologous Cytokine Rich Serum (ACRS) is produced from the patient’s blood. The effect of ACRS is based on the multiplication of the body’s own anti-inflammatory interleukins and growth factors. For this reason, our technology is a valuable tool for dermatologists to treat all types of skin inflammation with a completely autologous and thus very well tolerated therapy.

ACRS contains high concentrations of positive interleukins to regulate inflammation as well as growth factors. These growth factors play a crucial role in tissue regeneration. The finished serum is injected precisely into the skin areas where inflammation is to be regulated and tissue regeneration is to be supported.

In order to ensure a high level of tolerance, no artificial additives are used.